Paresh Patel - Apr 5, 2022 Form 4 Insider Report for HCI Group, Inc. (HCI)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Andrew L. Graham as Attorney-in-fact for Paresh Patel
Stock symbol: HCI
Transactions as of: Apr 5, 2022
Transactions value $: $103,800
Form type: 4
Date filed: 4/5/2022, 04:52 PM
Next filing: Aug 24, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCI	Common stock	Purchase	$104K	+1.5K	+4.29%	$69.20	36.5K	Apr 5, 2022	IRA
holding	HCI	Common Stock						273K	Apr 5, 2022	Direct
holding	HCI	Common stock						447K	Apr 5, 2022	Direct	F1
holding	HCI	Common Stock						10K	Apr 5, 2022	Direct	F2
holding	HCI	Common Stock						20K	Apr 5, 2022	Direct	F3
holding	HCI	Common Stock						30K	Apr 5, 2022	Direct	F4
holding	HCI	Common Stock						10K	Apr 5, 2022	Direct	F5
holding	HCI	Common Stock						10K	Apr 5, 2022	Direct	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HCI	Stock Option (Right to Buy)						110K	Apr 5, 2022	Common	110K	$40.00	Direct	F7, F8
holding	HCI	Stock Option (Right to Buy)						110K	Apr 5, 2022	Common	110K	$40.00	Direct	F7, F9
holding	HCI	Stock Option (Right to Buy)						110K	Apr 5, 2022	Common	110K	$53.00	Direct	F7, F10
holding	HCI	Stock Option (Right to Buy)						110K	Apr 5, 2022	Common	110K	$48.00	Direct	F7, F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held jointly with spouse.
F2	Restricted stock grant of 40,000 shares effective February 8, 2018: Restrictions on 10,000 shares have lapsed. Restrictions on the remaining 30,000 shares will lapse in 10,000 amounts on each of February 8, 2020, February 8, 2021, and February 8, 2022. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated February 8, 2018.
F3	Restricted stock grant of 40,000 shares effective January 15, 2019: Restrictions on 10,000 shares have lapsed. Restrictions on the remaining 30,000 shares will lapse in 10,000 amounts on each of January 15, 2021, January 15, 2022, and January 15, 2023. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 15, 2019.
F4	Restricted stock grant of 40,000 shares effective January 16, 2020: Restrictions on 10,000 shares will lapse on each of January 16, 2021, January 16, 2022, January 16, 2023, and January 16, 2024. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 16, 2020.
F5	Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest on October 5, 2022, which is the first anniversary of the date on which the company stock value first equaled or exceeded $105 for 30 consecutive trading days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.
F6	Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest, if ever, on the first anniversary of the date on which the company stock value first equals or exceeds $140 for 30 consecutive trading days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.
F7	The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.
F8	The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. Commencing on January 7, 2018 and continuing on the same day of each calendar year thereafter through and including January 7, 2021, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 7, 2027.
F9	The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. Commencing on February 8, 2019 and continuing on the same day of each calendar year thereafter through and including February 8, 2022, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including February 8, 2028.
F10	The options were granted on January 15, 2019 at an exercise price of $53.00 per share, in excess of the $47.94 market value. Commencing on January 15, 2020 and continuing on the same day of each calendar year thereafter through and including January 15, 2023, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 15, 2029.
F11	The options were granted on January 16, 2020 at an exercise price of $48.00 per share, in excess of the $45.97 market value. Commencing on January 16, 2021 and continuing on the same day of each calendar year thereafter through and including January 16, 2024, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 16, 2030.